Currently, the European Medicines Agency authorizes three vaccines against Covid-19.
First, Pfizer-BioNTech, followed by Moderna and AstraZeneca.
Unlike the first two, AstraZeneca is not an RNA (messenger ribonucleic acid) vaccine.
If the results of clinical trials showed it to be significantly less effective than RNA (60% effectiveness against more than 90% for the two RNA vaccines), the first data outside laboratories (mainly from the United Kingdom) indicate a more nuanced reality.
Our new tool, updated daily, allows you to monitor the proportion of different vaccines in France or in the department of your choice.
In addition to the dispersed arrival of these vaccines on the French market, other factors may explain the differences observed.
The question of stocks on hand and deliveries comes first.
The logistics for packaging and transport vary from vaccine to vaccine.
The Pfizer-BioNTech
This article is for subscribers only.
You have 38% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in
